These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32216101)

  • 1. Ethnic variability in newborn metabolic screening markers associated with false-positive outcomes.
    Peng G; Tang Y; Gandotra N; Enns GM; Cowan TM; Zhao H; Scharfe C
    J Inherit Metab Dis; 2020 Sep; 43(5):934-943. PubMed ID: 32216101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
    Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
    Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded newborn screening in New South Wales: missed cases.
    Estrella J; Wilcken B; Carpenter K; Bhattacharya K; Tchan M; Wiley V
    J Inherit Metab Dis; 2014 Nov; 37(6):881-7. PubMed ID: 24970580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of newborn screening disorders among 56632 infants in Central Saudi Arabia. A 6-year study.
    Mohamed S; Elsheikh W; Al-Aqeel AI; Alhashem AM; Alodaib A; Alahaideb L; Almashary M; Alharbi F; AlMalawi H; Ammari A; Almohaimeed S
    Saudi Med J; 2020 Jul; 41(7):703-708. PubMed ID: 32601637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of elevated tetradecenoyl-L-carnitine detected by newborn screening in New Zealand: implications for very long chain acyl-CoA dehydrogenase deficiency screening and treatment.
    Ryder B; Knoll D; Love DR; Shepherd P; Love JM; Reed PW; de Hora M; Webster D; Glamuzina E; Wilson C
    J Inherit Metab Dis; 2016 May; 39(3):409-414. PubMed ID: 26743058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.
    Bleeker JC; Kok IL; Ferdinandusse S; van der Pol WL; Cuppen I; Bosch AM; Langeveld M; Derks TGJ; Williams M; de Vries M; Mulder MF; Gozalbo ER; de Sain-van der Velden MGM; Rennings AJ; Schielen PJCI; Dekkers E; Houtkooper RH; Waterham HR; Pras-Raves ML; Wanders RJA; van Hasselt PM; Schoenmakers M; Wijburg FA; Visser G
    J Inherit Metab Dis; 2019 May; 42(3):414-423. PubMed ID: 30761551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a targeted metabolomics panel for improved second-tier newborn screening.
    Mak J; Peng G; Le A; Gandotra N; Enns GM; Scharfe C; Cowan TM
    J Inherit Metab Dis; 2023 Mar; 46(2):194-205. PubMed ID: 36680545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
    Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
    Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Serendipities of Expanded Newborn Screening.
    Yahyaoui R; Blasco-Alonso J; Gonzalo-Marín M; Benito C; Serrano-Nieto J; González-Gallego I; Ruiz-Sala P; Pérez B; González-Lamuño D
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32872442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.
    Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ
    Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive newborn screen in a normal infant of a mother with asymptomatic very long-chain Acyl-CoA dehydrogenase deficiency.
    McGoey RR; Marble M
    J Pediatr; 2011 Jun; 158(6):1031-2. PubMed ID: 21429517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing False-Positive Results in Newborn Screening Using Machine Learning.
    Peng G; Tang Y; Cowan TM; Enns GM; Zhao H; Scharfe C
    Int J Neonatal Screen; 2020 Mar; 6(1):. PubMed ID: 32190768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
    Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
    Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency.
    Hennermann JB; Roloff S; Gellermann J; Grüters A; Klein J
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S355-9. PubMed ID: 20033292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal insufficiency mimicking glutaric acidemia type 1 on newborn screening.
    Matsumoto M; Awano H; Bo R; Nagai M; Tomioka K; Nishiyama M; Ninchouji T; Nagase H; Yagi M; Morioka I; Hasegawa Y; Takeshima Y; Iijima K
    Pediatr Int; 2018 Jan; 60(1):67-69. PubMed ID: 29059480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of VLCAD deficiency phenotype by a metabolic fingerprint in newborn screening bloodspots.
    Knottnerus SJG; Pras-Raves ML; van der Ham M; Ferdinandusse S; Houtkooper RH; Schielen PCJI; Visser G; Wijburg FA; de Sain-van der Velden MGM
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165725. PubMed ID: 32061778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated methylmalonic acidemia (MMA) screening markers in Hispanic and preterm newborns.
    Peng G; de Fontnouvelle CA; Enns GM; Cowan TM; Zhao H; Scharfe C
    Mol Genet Metab; 2019 Jan; 126(1):39-42. PubMed ID: 30448007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.
    Schiff M; Mohsen AW; Karunanidhi A; McCracken E; Yeasted R; Vockley J
    Mol Genet Metab; 2013 May; 109(1):21-7. PubMed ID: 23480858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.